New Market Report: Neurofibromatoses Type I (Von Recklinghausen's Disease) - Pipeline Review, H2 2012
Global Markets Direct's, 'Neurofibromatoses Type I (Von Recklinghausen's Disease) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Neurofibromatoses Type I (Von Recklinghausen's Disease), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neurofibromatoses Type I (Von Recklinghausen's Disease). Neurofibromatoses Type I (Von Recklinghausen's Disease) - Pipeline Review, Half Year is built using...
View full press release